Golgi membrane protein 1 (GOLM1) has been reported to participate in modulating the immunosuppressive microenvironment and it has been implicated in the onset and progression of hepatocellular carcinoma, glioblastoma, and melanoma [44–46]. Here, GOLM1 is linked to glioblastoma.